TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the stock.

TherapeuticsMD Price Performance

TherapeuticsMD stock opened at $1.00 on Tuesday. TherapeuticsMD has a 12 month low of $0.70 and a 12 month high of $2.44. The stock has a fifty day simple moving average of $0.96 and a two-hundred day simple moving average of $1.24.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.